Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma

August 5, 2024 | Comments Off on Combined detection of SHOX2 and PTGER4 methylation with serum marker CYFRA21-1 for improved diagnosis of malignant pleural mesothelioma

Journal of Clinical Pathology 2024 July 26 [Link] Nana Zhang, Yongmeng Li, Zuyu Sun, Yujie Dong, Lijuan Zhou, Chen Zhang, Zichen Liu, Qiuyi Zhang, Kun Li, Fudong Xu, Li Zhang,…

Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through In-Depth Interviews

August 2, 2024 | Comments Off on Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): Cancer Survivors’ Perspective Through In-Depth Interviews

Annals of Surgical Oncology 2024 July 26 [Link] Luis Felipe Falla-Zuniga, Mary Caitlin King, Kathleen Pawlikowski, Andrei Nikiforchin, Felipe Lopez-Ramirez, Philipp Barakat, Sergei Iugai, Carol Nieroda, Vadim Gushchin, Armando Sardi…

The Role of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Thoracic Tumors

August 1, 2024 | Comments Off on The Role of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Thoracic Tumors

Cancers 2024 July 11 [Link] Federica Danuzzo, Maria Chiara Sibilia, Sara Vaquer, Andrea Cara, Enrico Mario Cassina, Lidia Libretti, Emanuele Pirondini, Federico Raveglia, Antonio Tuoro, Francesco Petrella Abstract Pleural mesothelioma…

Leucine rich α2 glycoprotein 1 derived from malignant pleural mesothelioma cells facilitates macrophage M2 phenotypes

July 31, 2024 | Comments Off on Leucine rich α2 glycoprotein 1 derived from malignant pleural mesothelioma cells facilitates macrophage M2 phenotypes

Experimental Lung Research 2024 [Link] Dandan Wang, Wenjing Pei, Yanfei Liu, Rongliang Mo, Xinru Li, Wenhui Gu, Yi Su, Jing Ye, Jiegou Xu, Dahai Zhao Abstract Background: Macrophages constitute the…

PSYCHOLOGICAL INTERVENTIONS FOR MESOTHELIOMA PATIENTS AND THEIR CAREGIVERS: A SYSTEMATIC LITERATURE REVIEW

July 30, 2024 | Comments Off on PSYCHOLOGICAL INTERVENTIONS FOR MESOTHELIOMA PATIENTS AND THEIR CAREGIVERS: A SYSTEMATIC LITERATURE REVIEW

Journal of Pain and Symptom Management 2024 July 17 [Link] Isabella Giulia Franzoi, Maria Domenica Sauta, Alessandra De Luca 2, Francesca Barbagli, Antonella Granieri Abstract Objective: Malignant Mesothelioma (MM) has…

Evaluating the anticancer potential of Polygonum multiflorum root-derived stilbenes against H2452 malignant pleural mesothelioma cells

July 29, 2024 | Comments Off on Evaluating the anticancer potential of Polygonum multiflorum root-derived stilbenes against H2452 malignant pleural mesothelioma cells

Fitoterapia 2024 July 22 [Link] Trung Huy Ngo, Yoon-Jin Lee, Hyukjae Choi, Kyung-Sik Song, Kyu Joon Lee, Joo-Won Nam Abstract A naturally occurring stilbene, resveratrol, shows promising effects in the…

Primary Peritoneal Mesothelioma Affecting the Greater Omentum That Mimicked an Omental Infarction: A Case Report

July 26, 2024 | Comments Off on Primary Peritoneal Mesothelioma Affecting the Greater Omentum That Mimicked an Omental Infarction: A Case Report

Case Reports in Oncology 2024 May 30 [Link] John Corbyn Cravero, Taylor Yakubik, Laith Wahab, Thao Giang, Lisa M Lopez, Megan G Newman Abstract Introduction: Malignant peritoneal mesothelioma (MPM) is…

Incidental Diagnosis of Malignant Peritoneal Mesothelioma During Liver Transplantation Surgery: A Case Report

July 25, 2024 | Comments Off on Incidental Diagnosis of Malignant Peritoneal Mesothelioma During Liver Transplantation Surgery: A Case Report

The American Journal of Case Reports 2024 July 17 [Link] Spogmai Khan, Adnan Malik, Shahbaz Qureshi, Babak Cohen, Abdul Nadir Abstract BACKGROUND Malignant peritoneal mesothelioma (MPM) is a rare, lethal…

Contemporary management of mesothelioma

July 24, 2024 | Comments Off on Contemporary management of mesothelioma

Breathe 2024 July 16 [Link] Mark D J Neilly, Jennifer Pearson, Akari Win Thu, Carolyn MacRae, Kevin G Blyth Abstract Pleural mesothelioma (PM) is an aggressive asbestos-associated thoracic malignancy with…

Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study

July 23, 2024 | Comments Off on Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma-Protocol of the Immuno-MESODEC study

PloS One 2024 July 15 [Link] Jolien Van den Bossche, Maxime De Laere, Koen Deschepper, Paul Germonpré, Yvan Valcke, Jan Lamont, Barbara Stein, Kirsten Van Camp, Charlotte Germonpré, Griet Nijs,…

Categories